Bahram Valamehr - Jun 14, 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Chief Development Officer
Signature
/s/ Cindy Tahl, Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Jun 14, 2021
Transactions value $
-$2,162,049
Form type
4
Date filed
6/16/2021, 04:26 PM
Next filing
Sep 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $46.9K +16.2K +16.87% $2.90 112K Jun 14, 2021 Direct F1
transaction FATE Common Stock Options Exercise $24.1K +8.84K +7.9% $2.73 121K Jun 14, 2021 Direct F1
transaction FATE Common Stock Sale -$1.46M -16.4K -13.57% $89.11* 104K Jun 14, 2021 Direct F1, F2
transaction FATE Common Stock Sale -$737K -8.22K -7.88% $89.68* 96.1K Jun 14, 2021 Direct F1, F3
transaction FATE Common Stock Sale -$36.3K -400 -0.42% $90.76* 95.7K Jun 14, 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -16.2K -100% $0.00* 0 Jun 14, 2021 Common Stock 16.2K $2.90 Direct F1, F5
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -8.84K -7.37% $0.00 111K Jun 14, 2021 Common Stock 8.84K $2.73 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020.
F2 Represents the weighted average sale price of the shares sold from $88.45 to $89.44 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4.
F3 Represents the weighted average sale price of the shares sold from $89.45 to $90.16 per share.
F4 Represents the weighted average sale price of the shares sold from $90.71 to $90.86 per share.
F5 This option is fully vested.